Mohammed T. Abou-Saleh

INDEX 809social support 96–7, 546depression and 384neurotic disorders and 546–7socioeconomic status 96Socio-emotional Selectivity Theory 379somatization 409, 417, 575–6somatoform disorders 538–9South America, mental illness in 651–2specific phobia see simple phobiaspinocerebella ataxias (SCA), subcorticaldementia in 270spinocerebellar atrophy associated withdementia 279spontaneous dyskinesia 531SSRIs 439–40stagingaxial and multi-axial 143–4dementia 142–4global 143Steele–Richardson–Olszewski syndrome278steroidal hormones, Alzheimer’s diseaseand 206Stockton Geriatric Rating Scale 169, 170stress 53, 545acute stress disorder (ASD) 553, 556life events and 82neurotic disorders and 546–7psychiatrists and 793schizophrenia and 96see also post-traumatic stress disorder;stress reactionstress reaction 538, 579–80stroke 319–20post-stroke depression (PSD) 386–7,425–6Structured Interview for Disorders ofPersonality scale (SIDP-R) 588subcortical dementia 188, 269–70, 295subcortical hyperintensities, incidence of39subcortical white matter dementia 255–6substance-induced anxiety 553, 556suicidal behavior/suicide 469–71biological factors 470epidemiology 469physical illness and 420, 470prevention 470–1, 780psychiatric illness 469–70rates 469social factors 469sundowning 154support networks 83–4Support/Efficacy Model 380supranuclear palsy 188Sydenham’s chorea 571Sydney Dementia Carers’ Training Program762–8tacrine 231tardive dyskinesia (TD) 523acute extrapyramidal side effects 530–1advancing age 527–8affective disorder and 529akathisia 530–1antipsychotic medication 528–9clinical features 527dementia and 530gender 529organicity 529parkinsonism 530–1prevalence, incidence and natural history527psychiatric diagnosis 529–30risk factors 527–31schizophrenia and 530TCAs 439–40, 441technology, changes in 7telecareconcepts and applications 685–6dementia and 686ethical issues 686teleconsultation 685telemedicine 685temporal lobe variant frontotemporaldementia 281–2terminal drop 2130 stage theory of adult cognitive development21TIDE 686Tourette’s syndrome 571toxic dementias 286toxic-metabolic abnormalities 295–6trainingcommunity services 707for psychiatrists 791–2psychogeriatric services 10, 737triazolam 565tricyclic antidepressants 63, 566–7twin studiesof Alzheimer’s disease genetics 213genetics of affective disorders 375–6UKcommunity care in 672day hospital and day care in 677–9history of health and social services657–9psychogeriatrics in 10research in 10undernutrition 750–1unipolar disorder 371–2USA1600–1900 13–14acute inpatient hospitalization 691ambulatory psychiatric care 697–702community mental health centers 690financing mental health care 691–4,694future of integrated services and financing694mental care managed care 692–4nursing home 690–1, 719–20outpatient psychiatric service settings689–90primary care 689private psychiatric hospitals 723–5psychiatric service settings 689–91structure and organization of mentalhealth services 689–91system of care in 689–95valproate (valproic acid) 63, 440in acute mania 485–6drug interactions 486in mania 480side effects 485–6vascular cognitive impairment (VCI)249vascular dementia 186–8, 294Alzheimer’s disease and 373assessment 253assessment scales 187clinical types 251–3cerebral amyloid angiopathy 253cortical infarcts 251–2lacunar infarction 252leukoaraiosis 252–3early-onset (EOVD) 274epidemiology 251international criteria for 249investigation 253–4management 253–4pathology 247–8prevalence 196risk factors 251subgroups 255–6treatment 254vascular disease, homocysteine and319venlafaxine 567visual impairment 781vitamin deficiency 750voluntary organizations in Great Britain10wandering 238, 637–8waste, accumulation of 20Ways of Coping Check List 170wear and tear view of aging 3Wernicke–Korsakoff syndrome 210,285white matter changesin Alzheimer’s disease 225dementia due to 247white matter lesions (WMLs) 186–7Wilson’s disease 295Wisconsin Card Sorting Test 281WPA/WHO consensus statements 655ziprasidone 524–5Zung Self-rating Depression Scale (ZSDS)159Index compiled by Annette Musker